Chemical Used to Replace BPA is Potentially Toxic
News Feb 03, 2016
Companies advertise BPA-free plastic as a safer version of products ranging from water bottles to sippy cups to toys. Many manufacturers stopped used bisphenol A, a chemical that is used to strengthen plastic, after studies linked it to early puberty and a rise in breast and prostate cancers
However, bisphenol S, or BPS, a common replacement for BPA in plastics, has also been linked to health risks. New UCLA-led research demonstrates some of the mechanisms that make BPS just as harmful as BPA. The study found that BPS speeds up embryonic development and disrupts the reproductive system in animals.
“Our study shows that making plastic products with BPA alternatives does not necessarily leave them safer,” said Nancy Wayne, the study’s senior author, a reproductive endocrinologist and professor of physiology at the David Geffen School of Medicine at UCLA. “Our findings are frightening — consider it the aquatic version of the canary in the coal mine.”
Wayne and her colleagues found that when zebrafish were exposed to either BPA or BPS at low levels — equivalent to the traces found in polluted river waters — their physiology at the embryonic stage changed in as quickly as 25 hours.
“Egg-hatching time accelerated, leading to premature birth,” said Wayne, who is also UCLA’s associate vice chancellor for research. “The embryos developed much faster than normal in the presence of BPA or BPS.”
The research team studied zebrafish because their transparent embryos make it relatively easy to “watch” cell growth as it occurs.
Using fluorescent-green protein tags, the researchers tracked the development of the animals’ reproductive endocrine brain cells, which control puberty and fertility. They discovered that the number of endocrine neurons increased up to 40 percent, suggesting that BPA overstimulates the reproductive system.
“Exposure to low levels of BPA had a significant impact on the embryos’ development of brain cells that control reproduction and the genes that control reproduction later in life,” Wayne said. “We saw many of these same effects with BPS found in BPA-free products. BPS is not harmless.”
Wayne’s lab plans to investigate in a future study whether, as she suspects, overstimulation of the neurons that regulate reproduction leads to premature puberty and disruption of the reproductive system.
Wayne practices what she preaches. After completing a study on BPA in 2008, she immediately discarded all of the plastic food containers in her home and replaced them with glass. She and her family purchase food and drinks packaged in glass whenever possible.
The researchers also were surprised to find that both BPA and BPS exert their effects partly through an estrogen system and partly through a thyroid hormone system.
“Most people think of BPA as mimicking the effects of estrogen,” Wayne said. “But our work shows that it also mimics the actions of thyroid hormone.”
Thyroid hormone has a significant influence on brain development during gestation, so the research could have important implications for understanding general embryonic and fetal development, including in humans, Wayne said.
Researchers have proposed that endocrine-disrupting chemicals may be contributing to the rise in premature human births and early onset of puberty over the past couple of decades in the U.S.
“Our data supports that hypothesis,” Wayne said. “If BPA is impacting a wide variety of animal species, then it’s likely to be affecting human health.”
BPA can leach into food and beverages, particularly under heat, from cans, baby bottles, food-storage containers and plastic tableware. It can also be found in contact lenses, eyeglass lenses, compact discs, water-supply pipes, cash register and ATM receipts, and dental sealants and composites. One study published in 2010 projected that by 2015, the U.S. and Europe would be manufacturing more than 5 million tons of products containing BPA per year.
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE